Felix Rey
7Patents
0h-index
21Co-inventors
41Inventor score
Filing activity: Mar 17, 2010 → Oct 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12415836B2 | Anti-dengue vaccines and antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11723968B2 | Stabilized recombinant hantaviral spike proteins comprising mutations in Gc | Chemistry; Metallurgy | 0 | Active |
| US11198706B2 | Anti-dengue vaccines and antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US8735346B2 | HCV-derived polypeptides and uses thereof | Physics | 0 | Active |
| US11111274B2 | Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10213413B2 | Antiviral agents directed against respiratory syncytial virus | Chemistry; Metallurgy | 0 | Active |
| US11926648B2 | Neutralising antibody against dengue for use in a method of prevention and/or treatment of Zika infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.